共 62 条
- [1] Lawitz E(2014)Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial The Lancet 383 515-523
- [2] Poordad F(2011)Boceprevir for untreated chronic HCV genotype 1 infection New England Journal of Medicine 364 1195-1206
- [3] Shepard CW(2005)Global epidemiology of hepatitis C virus infection The Lancet Infectious Diseases 5 558-567
- [4] Finelli L(2013)Epidemiology and natural history of HCV infection Nature Reviews Gastroenterology and Hepatology 10 553-562
- [5] Alter MJ(2011)Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews The Lancet 378 571-583
- [6] Hajarizadeh B(1995)Spread of bloodborne viruses among Australian prison entrants BMJ 310 285-288
- [7] Grebely J(2008)HIV risks associated with incarceration among injection drug users: implications for prison-based public health strategies Journal of Public Health 30 126-132
- [8] Dore GJ(2004)HIV in prison: what are the risks and what can be done? Sexual Health 1 107-113
- [9] Nelson PK(1997)Sexual and perinatal transmission of hepatitis C Hepatology 26 66S-70S
- [10] Crofts N(2002)Sexual activity as a risk factor for hepatitis C Hepatology 36 S99-S105